Nodal/Activin Signaling: A Novel Target for Pancreatic Cancer Stem Cell Therapy

被引：5
|
作者：
Donahue, Timothy R. [1 ,2 ,3 ,4 ]
Dawson, David W. [1 ,5 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Inst Mol Med, Los Angeles, CA 90095 USA
[5] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA
来源：
CELL STEM CELL | 2011年 / 9卷 / 05期
关键词：
D O I：
10.1016/j.stem.2011.10.006
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
引用
收藏
页码：383 / 384
页数：2
相关论文
共 50 条
  • [1] Nodal/Activin Signaling Drives Self-Renewal and Tumorigenicity of Pancreatic Cancer Stem Cells and Provides a Target for Combined Drug Therapy
    Lonardo, Enza
    Hermann, Patrick C.
    Mueller, Maria-Theresa
    Huber, Stephan
    Balic, Anamaria
    Miranda-Lorenzo, Irene
    Zagorac, Sladjana
    Alcala, Sonia
    Roderiguez-Arabaolaza, Iker
    Carlos Ramirez, Juan
    Torres-Ruiz, Raul
    Garcia, Elena
    Hidalgo, Manuel
    Alvaro Cebrian, David
    Heuchel, Rainer
    Lohr, Matthias
    Berger, Frank
    Bartenstein, Peter
    Aicher, Alexandra
    Heeschen, Christopher
    CELL STEM CELL, 2011, 9 (05) : 433 - 446
  • [2] Nodal/Activin Signaling Drives Self-Renewal and Tumorigenicity of Pancreatic Cancer Stem Cells and Provides a Target for Combined Drug Therapy (vol 9, pg 433, 2011)
    Lonardo, Enza
    Hermann, Patrick C.
    Mueller, Maria-Theresa
    Huber, Stephan
    Balic, Anamaria
    Miranda-Lorenzo, Irene
    Zagorac, Sladjana
    Alcala, Sonia
    Rodriguez-Arabaolaza, Iker
    Carlos Ramirez, Juan
    Torres-Ruiz, Raul
    Garcia, Elena
    Hidaldo, Manuel
    Alvaro Cebrian, David
    Heuchel, Rainer
    Loehr, Matthias
    Berger, Frank
    Bartenstein, Peter
    Aicher, Alexandra
    Heeschen, Christopher
    CELL STEM CELL, 2012, 10 (01) : 104 - 104
  • [3] Embryogenesis meets tumorigenesis: Nodal/activin signaling drives self-renewal and invasiveness of pancreatic cancer stem cells
    Lonardo, Enza
    Hermann, Patrick C.
    Mueller, Maria-Theresa
    Miranda-Lorenzo, Irene
    Heeschen, Christopher
    CANCER RESEARCH, 2011, 71
  • [4] Pancreatic cancer stem cells: Emerging target for designing novel therapy
    Li, Yiwei
    Kong, Dejuan
    Ahmad, Aamir
    Bao, Bin
    Sarkar, Fazlul H.
    CANCER LETTERS, 2013, 338 (01) : 94 - 100
  • [5] Prostate stem cell antigen (PSCA) is a potential therapy target for pancreatic cancer
    Ross, S
    Spencer, SD
    Strickland, L
    Lasky, LA
    Koeppen, H
    MODERN PATHOLOGY, 2002, 15 (01) : 142A - 143A
  • [6] Prostate stem cell antigen (PSCA) is a potential therapy target for pancreatic cancer
    Ross, S
    Spencer, SD
    Strickland, L
    Lasky, LA
    Koeppen, H
    LABORATORY INVESTIGATION, 2002, 82 (01) : 142A - 143A
  • [7] Novel pancreatic cancer stem cell surface biomarkers (CD19+31+45+133+) as target for pancreatic cancer therapy.
    Das, Jayanta K.
    Celli, Jonathan P.
    Ruiz, Marco A.
    CANCER RESEARCH, 2018, 78 (10) : 66 - 66
  • [8] Activin/Nodal Signaling Switches the Terminal Fate of Human Embryonic Stem Cell-derived Trophoblasts
    Sarkar, Prasenjit
    Randall, Shan M.
    Collier, Timothy S.
    Nero, Anthony
    Russell, Teal A.
    Muddiman, David C.
    Rao, Balaji M.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (14) : 8834 - 8848
  • [9] Hedgehog Signaling Pathway Is a New Target of Cancer Stem Cell Therapy for Breast Cancer Patients
    Tanaka, H.
    Nakamura, M.
    Sohzaki, M.
    Kai, M.
    Kubo, M.
    Ohnishi, H.
    Tanaka, M.
    Katano, M.
    CANCER RESEARCH, 2009, 69 (24) : 589S - 589S
  • [10] Cancer stem cell in the progression and therapy of pancreatic cancer
    Xu, Lantao
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2013, 18 : 795 - 802
12345